By contrast, exosomes carrying BAG6, another NKp30 ligand, are necessary to activate NK cells in order to eliminate chronic lymphocytic leukemia (CLL) cells, whereas soluble BAG6 lead to tumor evasion (106). Here, NCR3 is linked to neoplasm.